At present, the pathologist is an important member of the treatment team wh
o provides information and consultation for selecting treatment, estimating
prognosis and evaluating outcome. The pathologist's functions include pret
reatment microscopic diagnosis, intraoperative consultation and histopathol
ogic examination of tumor resection specimens. Tumor classification follows
international rules published by the UICC and the WHO. The strongest predi
ctors of outcome are the residual tumor (R) classification and the TNM/pTNM
classification of anatomic extent before treatment. The new 5th edition of
TNM (1997) contains some changes in the classification of gastric, colorec
tal and exocrine pancreatic carcinoma. There are some pathological features
which independently influence prognosis in addition to R and TNM. For the
most biological and molecular markers the prognostic significance remains t
o be proven. In future, the main objective of prognostic factor research wi
ll be the development of prognostic systems.